Abstract
As the SARS-CoV-2 virus, the cause of COVID-19, emerged in early 2020 and quickly spread across the globe, clinical molecular genetics laboratories experienced a dramatic drop in samples referred for clinical testing as non-critical healthcare appointments were postponed. These laboratories, utilizing years of expertise in a field of rapidly evolving new technologies and high throughput testing, as well as clinical technologists trained in high-complexity testing, large genetics laboratories stepped in the fill the gap, a measure that kept laboratories running and staff employed.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
